Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,929
Closed -$307K 845
2026
Q1
$307K Hold
6,929
﹤0.01% 739
2025
Q4
$346K Buy
+6,929
New +$290K ﹤0.01% 734
2023
Q4
Sell
-5,100
Closed -$393K 945
2023
Q3
$393K Hold
5,100
﹤0.01% 832
2023
Q2
$430K Hold
5,100
﹤0.01% 851
2023
Q1
$347K Hold
5,100
﹤0.01% 867
2022
Q4
$306K Hold
5,100
﹤0.01% 865
2022
Q3
$329K Buy
5,100
+400
+9% +$26K ﹤0.01% 856
2022
Q2
$216K Buy
+4,700
New +$222K ﹤0.01% 904
2022
Q1
Sell
-7,951
Closed -$543K 1022
2021
Q4
$543K Buy
7,951
+3,040
+62% +$219K ﹤0.01% 878
2021
Q3
$373K Buy
4,911
+1,800
+58% +$148K ﹤0.01% 937
2021
Q2
$261K Buy
+3,111
New +$229K ﹤0.01% 974

Other funds holding XPEL

Royce & Associates's XPEL Position: Q2 2026 in Review

Royce & Associates sold out of XPEL (XPEL) in Q2 2026, closing a stake of 6,929 shares — an estimated $307K sold.

Royce & Associates first reported a position in XPEL in Q2 2021 and held it in 11 quarters. The position peaked at $543K in Q4 2021. 210 funds tracked by Wall St. Rank hold XPEL as of Q2 2026.

  • Royce & Associates reported no remaining XPEL position as of Q2 2026 after selling out during the quarter.
  • Royce & Associates sold 6,929 XPEL shares in Q2 2026, an estimated $307K.
  • Royce & Associates first reported a position in XPEL in Q2 2021 and held it in 11 quarters.
  • Royce & Associates's XPEL position peaked at $543K in Q4 2021.
  • 210 funds tracked by Wall St. Rank held XPEL as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.